Use of a functional classification of anemia in myelodysplastic syndromes to identify subgroups of patients responsive to recombinant human-erythropoietin therapy

Saved in:
Bibliographic Details
Published inEuropean journal of haematology Vol. 56; no. 1-2; p. 106
Main Authors Bucalossi, A, Marotta, G, Bigazzi, C, Galieni, P, Vessihelli, F, Falbo, R, Dispensa, E
Format Journal Article
LanguageEnglish
Published England 01.01.1996
Subjects
Aged
Aged, 80 and over
Anemia - classification
Anemia - drug therapy
Anemia - genetics
Biomarkers
Erythropoietin - blood
Erythropoietin - therapeutic use
Female
Follow-Up Studies
Humans
Karyotyping
Male
Middle Aged
Myelodysplastic Syndromes - classification
Myelodysplastic Syndromes - drug therapy
Myelodysplastic Syndromes - genetics
Receptors, Transferrin - analysis
Recombinant Proteins - therapeutic use
Online AccessGet more information

Cover

More Information
ISSN:0902-4441
DOI:10.1111/j.1600-0609.1996.tb00311.x